{"product_id":"global-mri-contrast-agents-market-growth-2023-2029","title":"Global MRI Contrast Agents Market Growth 2023-2029","description":"\u003cp\u003eGlobal MRI Contrast Agents Market Growth 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eMRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “MRI Contrast Agents Industry Forecast” looks at past sales and reviews total world MRI Contrast Agents sales in 2022, providing a comprehensive analysis by region and market sector of projected MRI Contrast Agents sales for 2023 through 2029. With MRI Contrast Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world MRI Contrast Agents industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global MRI Contrast Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on MRI Contrast Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global MRI Contrast Agents market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MRI Contrast Agents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global MRI Contrast Agents.\u003c\/p\u003e\n\n\u003cp\u003eThe global MRI Contrast Agents market size is projected to grow from US$ 1354.7 million in 2022 to US$ 2049.1 million in 2029; it is expected to grow at a CAGR of 2049.1 from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eGlobal key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.\u003c\/p\u003e\n\n\u003cp\u003eIn terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of MRI Contrast Agents market by product type, application, key manufacturers and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nGadobutrol\u003cbr\u003e\nGadoterate Meglumine\u003cbr\u003e\nGadobenate Dimeglumine\u003cbr\u003e\nGadopentetate Dimeglumine\u003cbr\u003e\nGadoteridol\u003cbr\u003e\nGadodiamine\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nHospitals\u003cbr\u003e\nClinics\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nMexico\u003cbr\u003e\nBrazil\u003cbr\u003e\nAPAC\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nKorea\u003cbr\u003e\nSoutheast Asia\u003cbr\u003e\nIndia\u003cbr\u003e\nAustralia\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUK\u003cbr\u003e\nItaly\u003cbr\u003e\nRussia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\nEgypt\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nIsrael\u003cbr\u003e\nTurkey\u003cbr\u003e\nGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nBayer\u003cbr\u003e\nGuerbet Group\u003cbr\u003e\nBracco Imaging\u003cbr\u003e\nGE Healthcare\u003cbr\u003e\nBeiLu Pharma\u003cbr\u003e\nHengrui Medicine\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Addressed in this Report\u003c\/p\u003e\n\n\u003cp\u003eWhat is the 10-year outlook for the global MRI Contrast Agents market?\u003c\/p\u003e\n\n\u003cp\u003eWhat factors are driving MRI Contrast Agents market growth, globally and by region?\u003c\/p\u003e\n\n\u003cp\u003eWhich technologies are poised for the fastest growth by market and region?\u003c\/p\u003e\n\n\u003cp\u003eHow do MRI Contrast Agents market opportunities vary by end market size?\u003c\/p\u003e\n\n\u003cp\u003eHow does MRI Contrast Agents break out type, application?\u003c\/p\u003e\n\n\u003cp\u003eWhat are the influences of COVID-19 and Russia-Ukraine war?\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 94 Pages \/ MCW16234695","offer_id":47651007791410,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-mri-contrast-agents-market-growth-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}